Rare tumours
Rare cancers are often difficult to diagnose and treat, leaving patients with limited options and uncertainty. Alexion’s research focuses on identifying targeted therapies that can help patients live longer, healthier lives. We work to advance understanding of these complex conditions and develop meaningful treatment approaches through clinical research.
Turning research into real impact
We’re focused on uncovering the biology behind rare cancers and developing treatments that can make a measurable difference for patients.
-
Identifying the drivers of rare cancers
By learning what causes rare cancers to start and grow, researchers gain insight into how the disease behaves.
-
Advancing therapies with targeted action
That knowledge helps guide the development of treatments designed to better address the cancer and support patients.
-
Supporting early diagnosis and clinical access
By partnering with physicians and leading research centers, we help shorten the time to diagnosis and bring new therapies to patients as safely and effectively as possible.
